Overview

Selegiline in Outpatient Treatment for Cocaine Dependence - 1

Status:
Completed
Trial end date:
1996-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and clinical safety of selegiline in the treatment of cocaine dependence and to assess neurotoxicity (Magnetic Resonance Imaging, MRI) post-hoc as a possible variable for future stratification in clinical trials.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Treatments:
Cocaine
Selegiline